Medical Ebitda from 2010 to 2024

MPW Stock  USD 3.76  0.16  4.08%   
Medical Properties EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA will likely drop to about 382.8 M in 2024. During the period from 2010 to 2024, Medical Properties EBITDA regression line of quarterly data had mean square error of 96813.1 T and geometric mean of  244,758,820. View All Fundamentals
 
EBITDA  
First Reported
2004-06-30
Previous Quarter
223.4 M
Current Value
-587 M
Quarterly Volatility
110.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medical Properties financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Properties' main balance sheet or income statement drivers, such as Depreciation And Amortization of 633.5 M, Interest Expense of 390.6 M or Selling General Administrative of 152.9 M, as well as many indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.22 or PTB Ratio of 0.37. Medical financial statements analysis is a perfect complement when working with Medical Properties Valuation or Volatility modules.
  
Check out the analysis of Medical Properties Correlation against competitors.

Latest Medical Properties' Ebitda Growth Pattern

Below is the plot of the Ebitda of Medical Properties Trust over the last few years. It is Medical Properties' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medical Properties' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Medical Ebitda Regression Statistics

Arithmetic Mean474,343,266
Geometric Mean244,758,820
Coefficient Of Variation94.37
Mean Deviation343,539,858
Median382,815,629
Standard Deviation447,616,235
Sample Variance200360.3T
Range1.4B
R-Value0.74
Mean Square Error96813.1T
R-Squared0.55
Significance0
Slope74,317,705
Total Sum of Squares2805044.1T

Medical Ebitda History

2024382.8 M
2023684.6 M
20221.3 B
20211.4 B
20201.1 B
2019429.2 M
2018429 M

About Medical Properties Financial Statements

Medical Properties investors use historical fundamental indicators, such as Medical Properties' Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medical Properties. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA684.6 M382.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.